Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer
- 1 August 2002
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 50 (2) , 155-159
- https://doi.org/10.1007/s00280-002-0476-9
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: